Skip to ContentSkip to Navigation
breed in kennis  -  sterk in techniek
Over ons Praktische zaken Waar vindt u ons prof. dr. G.A.P. (Geke) Hospers

Publicaties

Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge

AI-based histopathology analysis predicts checkpoint inhibitor response in advanced melanoma and identifies patterns associated with response

Early Cessation of Adjuvant Anti-PD-1 Therapy in Stage III and IV Melanoma

Explaining increased locoregional failure following TNT in RAPIDO

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

Neoadjuvant Bevacizumab and Chemoradiotherapy for Locally Advanced Rectal Cancer: Long-Term Outcomes of a Multicentre Study

Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial

NTCP Models Predicting Bowel Toxicity After Total Neoadjuvant Treatment or Chemoradiation for Rectal Cancer in the RAPIDO Trial

Acute and Late Radiation-Related Toxicity After Treatment of Locally Advanced Rectal Cancer With Intensity Modulated Radiation Therapy Compared With 3-Dimensional Conformal Radiation Therapy in the RAPIDO Trial

Pers/media

‘Het mooie is dat je het microbioom kunt veranderen’

Darmflora beïnvloedt effectiviteit immunotherapie bij huidkanker

Effectiviteit darmflora beïnvloed immunotherapie bij huidkanker

Newly Approved PET Imaging Agent Solves Clinical Dilemmas in Breast Cancer Patients

Sustainable Development Goals

SDG 3 – Goede gezondheid en welzijnSDG 7 – Betaalbare en schone energieSDG 9 – Industrie, innovatie en infrastructuurSDG 16 – Vrede, rechtvaardigheid en sterke instellingen

Meer informatie over de Sustainable Development Goals.